Evolus (EOLS) Capital Expenditures Growth (3y) (2021 - 2026)
Evolus (EOLS) Capital Expenditures Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 6.52% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 232.22% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 34.64% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 147.53% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 28.56% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -15.83% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -61.38% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 89.86% |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 22.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.28% |
| Dec 31, 2025 | 37.49% |
| Sep 30, 2025 | 23.34% |
| Jun 30, 2025 | 43.88% |
| Mar 31, 2025 | 198.45% |
| Dec 31, 2024 | -61.11% |
| Sep 30, 2024 | -18.11% |
| Jun 30, 2024 | 437.17% |
| Mar 31, 2024 | 231.93% |
| Dec 31, 2023 | -34.21% |
| Sep 30, 2023 | 45.15% |
| Jun 30, 2023 | -33.42% |
| Mar 31, 2023 | -26.21% |
| Dec 31, 2022 | 125.61% |
| Sep 30, 2022 | 76.87% |
| Jun 30, 2022 | 32.02% |
| Mar 31, 2022 | -75.57% |
| Dec 31, 2021 | -174.92% |
| Sep 30, 2021 | 298.61% |